TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1.

Abstract:

:The mammalian target of rapamycin (mTOR) is a highly conserved serine-threonine kinase activated in response to growth factors and nutrients. Because of frequent dysregulation of the mTOR signaling pathway in diverse human cancers, this kinase is a key therapeutic target. Redd1 is a negative regulator of mTOR, mediating dissociation of 14-3-3 from tuberous sclerosis complex (TSC)2, which allows formation of a TSC-TSC2 complex. In the present study, we identify TXNIP that inhibits mTOR activity by binding to and stabilizing Redd1 protein. Redd1 and TXNIP expression was induced by a synthetic glucose analog, 2-deoxyglucose (2-DG). Moreover, Redd1 expression in response to 2-DG was regulated by activating transcription factor 4 (ATF4). Overexpression of TXNIP was associated with reduced mTOR activity mediated by an increase in Redd1 level, whereas knockdown of TXNIP using small interfering RNA resulted in recovery of mTOR activity via downregulation of Redd1 during treatment with 2-DG. Interestingly, Redd1 was additionally stabilized via interactions with N-terminal-truncated TXNIP, leading to suppression of mTOR activity. Our results collectively demonstrate that TXNIP stabilizes Redd1 protein induced by ATF4 in response to 2-DG, resulting in potentiation of mTOR suppression. To the best of our knowledge, this is the first study to identify TXNIP as a novel member of the mTOR upstream that acts as a negative regulator in response to stress signals.

journal_name

Oncogene

journal_title

Oncogene

authors

Jin HO,Seo SK,Kim YS,Woo SH,Lee KH,Yi JY,Lee SJ,Choe TB,Lee JH,An S,Hong SI,Park IC

doi

10.1038/onc.2011.102

subject

Has Abstract

pub_date

2011-09-01 00:00:00

pages

3792-801

issue

35

eissn

0950-9232

issn

1476-5594

pii

onc2011102

journal_volume

30

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells.

    abstract::LNCaP cells are human prostatic cancer cells that have a frame-shift mutation of the tumor suppressor gene PTEN and do not express the insulin receptor substrate-1 (IRS-1), a major substrate of the type 1 insulin-like growth factor receptor (IGF-IR). Ectopic expression of IRS-1 in LNCaP cells increases cell adhesion a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204112

    authors: Reiss K,Wang JY,Romano G,Tu X,Peruzzi F,Baserga R

    更新日期:2001-01-25 00:00:00

  • Detailed analysis of the basic domain of the E2F1 transcription factor indicates that it is unique among bHLH proteins.

    abstract::The E2F1 transcription factor binds to sites within the promoters of a number of cell cycle regulated genes through a basic-helix-loop-helix motif (bHLH). It is shown here that the basic region of E2F1 is distinct from that of all other bHLH proteins. The center of the basic region contains a helix breaking proline-gl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Jordan KL,Haas AR,Logan TJ,Hall DJ

    更新日期:1994-04-01 00:00:00

  • Studying the pathogenesis of BCR-ABL+ leukemia in mice.

    abstract::Animal models of BCR-ABL+ leukemias have provided important new knowledge about the molecular pathophysiology of these diseases, and answered questions that are difficult or impossible to address using BCR-ABL-expressing cell lines or primary Ph+ leukemia samples from patients. The power of mouse models lies in their ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206091

    authors: Van Etten RA

    更新日期:2002-12-09 00:00:00

  • PTEN functions as a melanoma tumor suppressor by promoting host immune response.

    abstract::Cancer cells acquire several traits that allow for their survival and progression, including the ability to evade the host immune response. However, the mechanisms by which cancer cells evade host immune responses remain largely elusive. Here we study the phenomena of immune evasion in malignant melanoma cells. We fin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.409

    authors: Dong Y,Richards JA,Gupta R,Aung PP,Emley A,Kluger Y,Dogra SK,Mahalingam M,Wajapeyee N

    更新日期:2014-09-18 00:00:00

  • RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer.

    abstract::Mice bred to carry germline Rb and p53 null alleles are associated with a tumor spectrum that overlaps with the inherited multiple endocrine neoplasia-1 (MEN1) and MEN2 syndromes in humans, including medullary thyroid cancer (MTC). To study the genetic basis for these tumors, we microdissected MTC specimens or obtaine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202381

    authors: Coxon AB,Ward JM,Geradts J,Otterson GA,Zajac-Kaye M,Kaye FJ

    更新日期:1998-09-24 00:00:00

  • Suppression of v-Src transformation in primary rat embryo fibroblasts.

    abstract::To understand the mechanism for resistance of primary cultures of rat embryo fibroblasts (REFs) to oncogene-induced transformation, we studied the transforming ability of a recombinant retrovirus, ZSV, containing v-src and neo genes in REFs and in the rat cell line F2408. The susceptibility of REFs to p60v-src transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Inoue H,Tavoloni N,Hanafusa H

    更新日期:1995-07-20 00:00:00

  • Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.

    abstract::Ras genes, frequently mutated in human tumors, promote malignant transformation. Ras transformation requires membrane anchorage, which is promoted by Ras farnesylcysteine carboxymethylester and by a second signal. Previously we showed that the farnesylcysteine mimetic, farnesylthiosalicylic acid (FTS) disrupts Ras mem...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204950

    authors: Paz A,Haklai R,Elad-Sfadia G,Ballan E,Kloog Y

    更新日期:2001-11-08 00:00:00

  • Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.

    abstract::The Rel/NF-kappaB transcription factors regulate the expression of many genes. The activity of RelA, a member of the Rel/NF-kappaB transcription factor family, is constitutively activated in the majority of pancreatic adenocarcinomas and cell lines. We report that the urokinase-type plasminogen activator (uPA), one of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202833

    authors: Wang W,Abbruzzese JL,Evans DB,Chiao PJ

    更新日期:1999-08-12 00:00:00

  • RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface.

    abstract::MEN 2B (multiple endocrine neoplasia type 2B) is an autosomal dominant cancer syndrome caused by an oncogenic form of the receptor tyrosine kinase REarranged during transfection (RET). The MEN 2B syndrome is associated with an abnormal autophosphorylation of the mutated receptor even without ligand-stimulation. Here, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210591

    authors: Runeberg-Roos P,Virtanen H,Saarma M

    更新日期:2007-12-13 00:00:00

  • No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.

    abstract::A growing body of literature suggests that the ubiquitously expressed Src family kinases (Src, Fyn and Yes) are required for agents such as platelet-derived growth factor (PDGF) to stimulate DNA synthesis. Yet Klinghoffer and colleagues recently presented evidence that fibroblasts derived from mice null for Src, Fyn a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203608

    authors: Broome MA,Courtneidge SA

    更新日期:2000-06-01 00:00:00

  • Mutant p53: an oncogenic transcription factor.

    abstract::Inactivation of tumor-suppressor genes is one of the key hallmarks of a tumor. Unlike other tumor-suppressor genes, p53 is inactivated by missense mutations in half of all human cancers. It has become increasingly clear that the resulting mutant p53 proteins do not represent only the mere loss of wild-type p53 tumor s...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210296

    authors: Strano S,Dell'Orso S,Di Agostino S,Fontemaggi G,Sacchi A,Blandino G

    更新日期:2007-04-02 00:00:00

  • ATM kinase activity modulates ITCH E3-ubiquitin ligase activity.

    abstract::Ataxia Telangiectasia Mutated (ATM) kinase, a central regulator of the DNA damage response, regulates the activity of several E3-ubiquitin ligases, and the ubiquitination-proteasome system is a consistent target of ATM. ITCH is an E3-ubiquitin ligase that modulates the ubiquitination of several targets, therefore part...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.52

    authors: Santini S,Stagni V,Giambruno R,Fianco G,Di Benedetto A,Mottolese M,Pellegrini M,Barilà D

    更新日期:2014-02-27 00:00:00

  • Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family.

    abstract::Treatment of cells with insulin and protein tyrosine phosphatase inhibitors such as vanadate and pervanadate resulted in the tyrosine phosphorylation of Grb10, a Src homology 2 (SH2) and pleckstrin homology domain-containing adaptor protein which binds to a number of receptor tyrosine kinases including the insulin rec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203616

    authors: Langlais P,Dong LQ,Hu D,Liu F

    更新日期:2000-06-08 00:00:00

  • Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.

    abstract::The 2;13 chromosomal translocation occurs in most cases of the cancer alveolar rhabdomyosarcoma (ARMS), and juxtaposes the genes encoding the PAX3 and FKHR transcription factors. The resulting chimeric protein PAX3-FKHR is a potent transcriptional activator, and is hypothesized to function as a dominant acting oncogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207850

    authors: Xia SJ,Barr FG

    更新日期:2004-09-09 00:00:00

  • MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.

    abstract::Ewing sarcoma is a pediatric bone tumor characterized in 85% of cases by the fusion between EWS and FLI1 genes that results in the expression of the EWS-FLI1 aberrant transcription factor. Histologically, the Ewing tumor expresses high levels of the CD99 membrane glycoprotein. It has been recently described that CD99 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.403

    authors: Franzetti GA,Laud-Duval K,Bellanger D,Stern MH,Sastre-Garau X,Delattre O

    更新日期:2013-08-15 00:00:00

  • MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2.

    abstract::Osteoclasts are multinuclear bone-resorbing cells that differentiate from hematopoietic precursor cells. Prostate cancer cells frequently spread to bone and secrete soluble signaling factors to accelerate osteoclast differentiation and bone resorption. However, processes and mechanisms that govern the expression of os...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0356-3

    authors: Kim JM,Shin Y,Lee S,Kim MY,Punj V,Shin HI,Kim K,Koh JM,Jeong D,An W

    更新日期:2018-10-01 00:00:00

  • UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.

    abstract::An improved understanding of the biochemical alterations that accompany tumor progression and metastasis is necessary to inform the next generation of diagnostic tools and targeted therapies. Metabolic reprogramming is known to occur during the epithelial-mesenchymal transition (EMT), a process that promotes metastasi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0885-4

    authors: Arnold JM,Gu F,Ambati CR,Rasaily U,Ramirez-Pena E,Joseph R,Manikkam M,San Martin R,Charles C,Pan Y,Chatterjee SS,Den Hollander P,Zhang W,Nagi C,Sikora AG,Rowley D,Putluri N,Zhang XH,Karanam B,Mani SA,Sreekumar A

    更新日期:2020-04-01 00:00:00

  • DNA adduct burden and tobacco carcinogenesis.

    abstract::DNA adducts associated with tobacco smoking could provide a marker of biologically effective dose of tobacco carcinogens and improve individual cancer risk prediction. A significant number of clinical and epidemiologic studies have reported associations of increased DNA adduct levels with the occurrence of the prevale...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205799

    authors: Wiencke JK

    更新日期:2002-10-21 00:00:00

  • Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma.

    abstract::Keratinocytes undergo a dramatic phenotypic conversion during reepithelialization of skin wounds to become hyperproliferative, migratory, and invasive. This transient healing response phenotypically resembles malignant transformation of keratinocytes during squamous cell carcinoma progression. Here we present the firs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206614

    authors: Pedersen TX,Leethanakul C,Patel V,Mitola D,Lund LR,Danø K,Johnsen M,Gutkind JS,Bugge TH

    更新日期:2003-06-19 00:00:00

  • Radiation-induced transgenerational alterations in genome stability and DNA damage.

    abstract::Mutation induction in directly exposed cells is currently regarded as the main component of the genetic risk of ionizing radiation for humans. However, recent data on the transgenerational increases in mutation rates in the offspring of irradiated parents indicate that the genetic risk could be greater than predicted ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209723

    authors: Barber RC,Hickenbotham P,Hatch T,Kelly D,Topchiy N,Almeida GM,Jones GD,Johnson GE,Parry JM,Rothkamm K,Dubrova YE

    更新日期:2006-11-30 00:00:00

  • Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

    abstract::Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that FABP4 in endothelial cells is induced by the NOTCH1 signalling pathway, the latter of which is involved in mechanisms of resistance to antiangiogenic tumour therapy. Here, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.256

    authors: Harjes U,Bridges E,Gharpure KM,Roxanis I,Sheldon H,Miranda F,Mangala LS,Pradeep S,Lopez-Berestein G,Ahmed A,Fielding B,Sood AK,Harris AL

    更新日期:2017-02-16 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues.

    abstract::While screening a chicken kidney cDNA library for the normal homolog of the yes oncogene, we isolated a clone that encodes a novel non-receptor type protein tyrosine kinase of the Src family. We named this gene product Yrk (York), as an acronym for Yes-related kinase. As predicted from the cDNA sequence, the Yrk prote...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sudol M,Greulich H,Newman L,Sarkar A,Sukegawa J,Yamamoto T

    更新日期:1993-04-01 00:00:00

  • CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.

    abstract::Tumor suppressor gene CDKN2 (also called MTS1, CDK4I and p16INK4) is located in 9p21 and deleted homozygously in a high percentage of tumor cell lines. We have examined the sequence of CDKN2 in 154 tumor cell lines that are not homozygously deleted for CDKN2. Overall, 18% (27/154) of the cell lines carried mutations i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Liu Q,Neuhausen S,McClure M,Frye C,Weaver-Feldhaus J,Gruis NA,Eddington K,Allalunis-Turner MJ,Skolnick MH,Fujimura FK

    更新日期:1995-03-16 00:00:00

  • PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.

    abstract::The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we presen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.192

    authors: Xenaki G,Ontikatze T,Rajendran R,Stratford IJ,Dive C,Krstic-Demonacos M,Demonacos C

    更新日期:2008-10-02 00:00:00

  • Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.

    abstract::B-Myb, a highly conserved member of the Myb oncoprotein family, is a 110 kDa sequence-specific DNA binding protein expressed in virtually all proliferating cells. B-myb expression reaches its maximum at the G1/S phase boundary and during the S phase of the cell cycle. We have previously shown that B-Myb activity is ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203618

    authors: Charrasse S,Carena I,Brondani V,Klempnauer KH,Ferrari S

    更新日期:2000-06-15 00:00:00

  • Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.

    abstract::Growing evidence demonstrates that hepatitis B virus (HBV) integration and resulting insertional mutagenesis play an important role in cell growth or maintenance in hepatocellular carcinomas (HCCs). To determine if HBV integration occurs and affects cellular genes at such a stage of infection, we analysed viral-host j...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208628

    authors: Minami M,Daimon Y,Mori K,Takashima H,Nakajima T,Itoh Y,Okanoue T

    更新日期:2005-06-23 00:00:00

  • GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.

    abstract::GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.480

    authors: Sun P,Nallar SC,Kalakonda S,Lindner DJ,Martin SS,Kalvakolanu DV

    更新日期:2009-03-12 00:00:00

  • Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.

    abstract::Glycolysis is critical for cancer stem cell reprogramming; however, the underlying regulatory mechanisms remain elusive. Here, we show that pyruvate dehydrogenase kinase 1 (PDK1) is enriched in breast cancer stem cells (BCSCs), whereas depletion of PDK1 remarkably diminishes ALDH+ subpopulations, decreases stemness-re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.368

    authors: Peng F,Wang JH,Fan WJ,Meng YT,Li MM,Li TT,Cui B,Wang HF,Zhao Y,An F,Guo T,Liu XF,Zhang L,Lv L,Lv DK,Xu LZ,Xie JJ,Lin WX,Lam EW,Xu J,Liu Q

    更新日期:2018-02-22 00:00:00

  • cdc2-like kinase is associated with the retinoblastoma protein.

    abstract::The growth-suppressive activity of the retinoblastoma (RB) protein is suggested to be regulated by phosphorylation. In studies on the kinase that phosphorylates the RB proteins, we have previously found that RB proteins can be phosphorylated by purified cdc2 kinase. In this study, we noted that RB proteins immunopreci...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitagawa M,Saitoh S,Ogino H,Okabe T,Matsumoto H,Okuyama A,Tamai K,Ohba Y,Yasuda H,Nishimura S

    更新日期:1992-06-01 00:00:00